Fatal SARS-CoV-2 infection in a renal transplant recipient.
CEN Case Rep
; 9(4): 409-412, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: covidwho-610154
ABSTRACT
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2) caused a pandemic that first discovered in Wuhan, China. While 10% of the patients have asymptomatic infection, 15-20% have lung involvement, 5-10% have multiple organ failure, and macrophage activation syndrome. Chronic respiratory diseases, diabetes mellitus, hypertension, and cancer are risk factors for mortality. Prognosis or optimal treatment strategy for renal transplant recipients in SARS-CoV-2 infection is still unknown. Besides fatal cases, there were also milder case reports. In addition, COVID-19 treatment and the maintenance immunosuppression strategy is still under debate. Antiviral therapies and drug interactions are special topics for these patients. To the best of our knowledge, favipiravir and anti-cytokine treatments have not been previously reported in a kidney transplant recipient with SARS-CoV-2 infection before. We report a case of SARS-CoV-2 infection in a kidney transplant recipient with fatal outcomes.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Neumonía Viral
/
Trasplante de Riñón
/
Infecciones por Coronavirus
/
Azitromicina
/
Pandemias
/
Betacoronavirus
/
Hidroxicloroquina
/
Inmunosupresores
/
Fallo Renal Crónico
/
Insuficiencia Multiorgánica
Tipo de estudio:
Reporte de caso
/
Estudios diagnósticos
/
Estudio pronóstico
Límite:
Femenino
/
Humanos
/
Middle aged
Idioma:
Inglés
Revista:
CEN Case Rep
Año:
2020
Tipo del documento:
Artículo
País de afiliación:
S13730-020-00496-4
Similares
MEDLINE
...
LILACS
LIS